ArticleClinical & translational immunology2016
Treg activation defect in type 1 diabetes: correction with TNFR2 agonism.
Yoshiaki Okubo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
64 papers cite itlatest 60 shown
this paperpooled ittrialcites it